https://www.prnewswire.com/news-releases/abbvie-expands-immunology-portfolio-in-the-us-with-fda-approval-of-skyrizi-risankizumab-rzaa-for-moderate-to-severe-plaque-psoriasis-300836934.html
SKYRIZI
First global regulatory approval of SKYRIZI (risankizumab) in Japan
https://www.biospectrumasia.com/news/28/13108/abbvie-gets-the-first-global-regulatory-approval-of-skyrizi-in-japan.html